MAGI2‐AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2Xu, XiaolongJohn Wiley and Sons2020DOI 10.1002/jcp.29922
Long Noncoding RNA MAGI2-AS3 Inhibits Bladder Cancer Progression Through MAGI2/PTEN/epithelial-mesenchymal Transition (EMT) AxisShen, DaqingIOS Press2020DOI 10.3233/cbm-201421
MAGI2 Mutations Cause Congenital Nephrotic SyndromeBierzynska, A.Lippincott Williams and Wilkins2016DOI 10.1681/asn.2016040387
MAGI2 Gene Region and Celiac DiseaseJauregi-Miguel, AmaiaFrontiers Media SA2019DOI 10.3389/fnut.2019.00187
Disruption of MAGI2-RapGEF2-Rap1 Signaling Contributes to Podocyte Dysfunction in Congenital Nephrotic Syndrome Caused by Mutations in MAGI2Zhu, BingbingKidney International2019DOI 10.1016/j.kint.2019.03.016
Roles of lncRNA MAGI2-AS3 in Human CancersKai-xin, LiuElsevier BV2021DOI 10.1016/j.biopha.2021.111812
Novel Insights for lncRNA MAGI2-AS3 in Solid TumorsXue, ChenElsevier BV2021DOI 10.1016/j.biopha.2021.111429
MAGI2 Genetic Variation and Inflammatory Bowel DiseaseDermot P.B. McGovernJohn Wiley and Sons2009DOI 10.1002/ibd.20611
MAGI2 Is an Independent Predictor of Biochemical Recurrence in Prostate CancerDavid, Stephanie N.John Wiley and Sons2018DOI 10.1002/pros.23506
Role of MAGI2-AS3 in Malignant and Non-malignant DisordersMohammad TaheriPathology - Research and Practice2023DOI 10.1016/j.prp.2023.154530